These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1718055)

  • 1. Regional effects on the cerebral concentration of noradrenaline, serotonin and dopamine in suckling rats after a single dose of lindane.
    Rivera S; Sanfeliu C; Suñol C; Rodríguez-Farré E
    Toxicology; 1991; 69(1):43-54. PubMed ID: 1718055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional concentrations of GABA, serotonin and noradrenaline in brain at onset of seizures induced by lindane (gamma-hexachlorocyclohexane).
    Suñol C; Tusell JM; Gelpí E; Rodríguez-Farré E
    Neuropharmacology; 1988 Jul; 27(7):677-81. PubMed ID: 2458533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and monoaminergic changes after lindane exposure in developing rats.
    Rivera S; Rosa R; Martínez E; Suñol C; Serrano MT; Vendrell M; Rodríguez-Farré E; Sanfeliu C
    Neurotoxicol Teratol; 1998; 20(2):155-60. PubMed ID: 9580350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and utilization of neurotransmitters: actions of subconvulsant doses of hexachlorocyclohexane isomers on brain monoamines.
    Artigas F; Martínez E; Camón L; Rodríguez Farré E
    Toxicology; 1988 Apr; 49(1):49-55. PubMed ID: 2453940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lindane on brain monoamine metabolism.
    Aldegunde M; Miguez I; Parafita M; Duran R
    Gen Pharmacol; 1986; 17(6):633-5. PubMed ID: 2434386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convulsant effect of lindane and regional brain concentration of GABA and dopamine.
    Suñol C; Tusell JM; Gelpí E; Rodríguez-Farré E
    Toxicology; 1988 May; 49(2-3):247-52. PubMed ID: 2453942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of (-)-trans-delta 9-tetrahydrocannabinol on regional brain levels and subcellular distribution of monoamines in the rat.
    Taylor DA; Fennessy MR
    Clin Exp Pharmacol Physiol; 1979; 6(5):541-8. PubMed ID: 498594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the levels of biogenic amines and superoxide anion production in brain regions of rats after subchronic exposure to TCDD.
    Byers JP; Masters K; Sarver JG; Hassoun EA
    Toxicology; 2006 Dec; 228(2-3):291-8. PubMed ID: 17070641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute administration of cyclazocine on the metabolism of biogenic amines in different regions of rat brain.
    Gavend MM; Serre F; Gavend MR; Ragoucy C; Caron P
    Psychopharmacology (Berl); 1981; 75(1):79-83. PubMed ID: 6171003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nickel on the levels of dopamine, noradrenaline and serotonin in different regions of the rat brain.
    Fatehyab S; Hasan M; Hasan MZ; Anwar J
    Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):318-20. PubMed ID: 7468231
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in biogenic amines in rat hippocampus during development and aging.
    Santiago M; Machado A; Reinoso-Suárez F; Cano J
    Life Sci; 1988; 42(24):2503-8. PubMed ID: 2453775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats.
    Venero JL; Machado A; Cano J
    Mech Ageing Dev; 1990 Dec; 56(3):253-63. PubMed ID: 2089199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
    Waldmeier PC; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):20-6. PubMed ID: 6195533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain.
    Stancheva S; Grahovska T; Petkov VV
    Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
    Ahtee L; Attila LM; Carlson KR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):803-8. PubMed ID: 2243351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of toluene inhalation on brain biogenic amines in the rat.
    Rea TM; Nash JF; Zabik JE; Born GS; Kessler WV
    Toxicology; 1984 May; 31(2):143-50. PubMed ID: 6740691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of some quinolizidine derivatives on the release of serotonin, noradrenaline, dopamine and acetylcholine from rat brain synaptosomes.
    Sparatore A; Marchi M; Maura G; Raiteri M
    Farmaco; 1989 Dec; 44(12):1205-16. PubMed ID: 2634407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of T-2 toxin on brain biogenic monoamines in rats and chickens.
    Boyd KE; Fitzpatrick DW; Wilson JR; Wilson LM
    Can J Vet Res; 1988 Apr; 52(2):181-5. PubMed ID: 2453262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of idebenone (CV-2619) on metabolism of monoamines, especially serotonin, in the brain of normal rats and rats with cerebral ischemia.
    Narumi S; Nagai Y; Kakihana M; Yamazaki N; Nagaoka A; Nagawa Y
    Jpn J Pharmacol; 1985 Mar; 37(3):235-44. PubMed ID: 2582171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the nootropic agents adafenoxate and meclofenoxate on brain biogenic monoamines in aged rats.
    Stancheva SL; Petkov VD; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):14-21. PubMed ID: 3136616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.